- Home
- KRP vs KURA Comparison
KRP vs KURA Comparison
Compare KRP & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KRP | KURA |
|---|---|---|
| Founded | 2013 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | KRP | KURA |
|---|---|---|
| Price | $11.80 | $10.44 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 11 |
| Target Price | $17.50 | ★ $25.00 |
| AVG Volume (30 Days) | 613.6K | ★ 1.7M |
| Earning Date | 11-06-2025 | 11-04-2025 |
| Dividend Yield | ★ 14.01% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $315,520,668.00 | $104,029,000.00 |
| Revenue This Year | $7.04 | $138.16 |
| Revenue Next Year | $0.92 | $67.37 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.98 | $5.41 |
| 52 Week High | $16.59 | $12.49 |
Technical Indicators
Market Signals| Indicator | KRP | KURA |
|---|---|---|
| Relative Strength Index (RSI) | 28.17 | 44.14 |
| Support Level | $12.21 | $10.17 |
| Resistance Level | $13.04 | $10.90 |
| Average True Range (ATR) | 0.29 | 0.59 |
| MACD | -0.06 | -0.22 |
| Stochastic Oscillator | 7.35 | 10.93 |
Price Performance
Historical ComparisonAbout KRP Kimbell Royalty Partners
Kimbell Royalty Partners LP owns and acquires mineral and royalty interests in oil and natural gas properties throughout the United States. The company's basins and producing regions include areas of interest in the Permian Basin, Mid-Continent, Terryville/Cotton Valley/Haynesville, Appalachian Basin, Eagle Ford, Bakken/Williston Basin, and DJ Basin/Rockies/Niobrara. Its revenues are derived from royalty payments received from operators based on the sale of oil, natural gas and NGL production, as well as the sale of NGLs that are extracted from natural gas during processing.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.